Search For "sars cov"
New study reveals high prevalence of post COVID-19 fatigue in patients wit
Updated : 4 years, 4 months ago IST
New Delhi [India], November 11 (ANI): Post-COVID-19 syndrome (PCS) or Long COVID has emerged as a major roadblock in the recovery of patients infected with SARS-CoV-2. Amidst many symptoms such as myalgia (muscle pain), headache, cough and breathlessness, fatigue is most prevalent and makes
Read More
Immune system early responder can combat COVID-19: Study
Updated : 4 years, 4 months ago IST
Washington [US], November 11 (ANI): A simple RNA molecule jumpstarts the immune system's 'first responders' to viral infection and can even eradicate the SARS-CoV-2 virus in mice with chronic cases of COVID-19, a new Yale School of Medicine study found.
Read More
The older you are, the more antibodies you have: Study
Updated : 4 years, 4 months ago IST
Washington [US], November 9 (ANI): With the emergence of SARS-CoV-2 variants worldwide, the pandemic's spread is accelerating. A research team led by Joelle Pelletier and Jean-Francois Masson, both professors in Universite de Montreal's Department of Chemistry, wanted to find out whether nat
Read More
Sewage sampling tells if there is increase in COVID viral load in particul
Updated : 4 years, 4 months ago IST
Bengaluru (Karnataka) [India], November 7 (ANI): The Bruhat Bengaluru Mahanagara Palike (BBMP) Chief Commissioner on Saturday said that sewage sampling is a new thing identified by INSACOG (Indian SARS-CoV-2 Genomics Consortium) that tells if there is an increase in COVID-19 viral load in
Read More
Researchers detect SARS-CoV-2 variant in dogs, cats with suspected myocard
Updated : 4 years, 4 months ago IST
Washington [US], November 5 (ANI): A new study in the Veterinary Record reveals that pets can be infected with the alpha variant of SARS-CoV-2, which was first detected in southeast England and is commonly known as the UK variant or B.1.1.7.
Read More
Sequencing respiratory viruses provides new insight on coinfections
Updated : 4 years, 4 months ago IST
Washington [US], November 1 (ANI): With mask-wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that has enabled the simultaneous testing for SARS-CoV-2 along with other common respiratory viruses, that tells whether oth
Read More
Researchers identify potential new treatment for COVID-19
Updated : 4 years, 4 months ago IST
Canterbury [UK], October 29 (ANI): Researchers during a recent study identified a potential new treatment that suppresses the replication of SARS-CoV-2, the virus that causes COVID-19.
Read More
LumiraDx receives approval for its COVID-19 Antigen test for use in India
Updated : 4 years, 4 months ago IST
London [UK], October 20 (ANI/NewsVoir): Today, LumiraDx, a next-generation point of care diagnostics testing company announced it has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in India.
Read More
WHO establishes new group to study origins of coronavirus
Updated : 4 years, 5 months ago IST
Geneva [Switzerland], October 14 (ANI): The World Health Organization (WHO) has launched an expert group that will study the origins of new pathogens, including SARS-CoV-2, the coronavirus that causes COVID-19.
Read More
COVID-19: Beijing's vaccine diplomacy fails as countries look to the West
Updated : 4 years, 5 months ago IST
Beijing [China] October 4 (ANI): Countries that once relied on COVID-19 vaccines from Beijing have now turned up to jabs from the Western countries amid the growing concerns about Chinese vaccines' efficiency against the Delta variant of SARS-CoV-2.
Read More
No new COVID-19 variant of concern has emerged, says Dr NK Arora
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): No new variant of concern (VOC) or variant of interest (VOI) of COVID-19 has emerged in the country, said Dr NK Arora, co-chair of the Indian SARS-CoV-2 Genomics Consortium (INSACOG), on Sunday.
Read More
Study shows inhibiting targets of SARS-CoV-2 proteases can block infection
Updated : 4 years, 5 months ago IST
Liverpool [UK], September 21 (ANI): Researchers at the University of Liverpool have shown how SARS-CoV-2 viral proteases attack the host cell, and how this can be targeted to stop virus replication in cell culture using existing drugs.
Read More